Bristol/AZ Saxagliptin Review Deadline Pushed Back; Tea Leaves Still Look Good For Approval
Bristol and FDA are working on cardiovascular outcomes study proposal. New deadline is July 30.
Bristol and FDA are working on cardiovascular outcomes study proposal. New deadline is July 30.